Fox Chase Cancer Center News

CHICAGO, IL (June 2, 2012)––Nearly half of the research presented at ASCO’s annual meeting last year came from researchers with ties to companies, and the amount appears to be increasing every year, according to new findings from Fox Chase Cancer Center. The new findings will be presented this year at the 2012 American Society of Clinical Oncology Annual Meeting on Monday, June 4.

CHICAGO, IL (April 4, 2012)—When combined with other treatments, the drug cetuximab—which works by slowing or stopping the growth of cancer cells—has been shown to extend survival in certain types of cancer, including metastatic colorectal cancers.  Unfortunately, about 40 percent of colorectal cancer patients—specifically those who carry a mutated form of a gene called KRAS—do not respond to the drug.  Researchers at Fox Chase Cancer Center in Philadelphia, however, have been working on a way to overcome this resistance to cetuximab by unleashing a second cetuximab d

CHICAGO, IL (April 4, 2012)—Inflammatory breast cancer (IBC) is a very aggressive, often misunderstood type of cancer that is diagnosed more frequently in younger women compared with other types of breast cancer. The five-year survival rate is between 25 and 50 percent—significantly lower than the survival rate for other types of breast cancer. The reason for the poor prognosis is that IBC usually grows rapidly and often spreads quickly to other parts of the body, including the brain, bone and lymph nodes.

CHICAGO, IL (April 3, 2012) – Scientists at Fox Chase Cancer Center in Philadelphia have come one step closer to developing the first treatment to target a key pathway in lymphoma.  The new findings will be announced at the AACR Annual Meeting 2012 on Tuesday, April 3.

CHICAGO, IL (April 3, 2012) – The hormone estrogen may help promote lung cancer— including compounding the effects of tobacco smoke on the disease—pointing towards potential new therapies that target the hormone metabolism, according to new research presented at the AACR Annual Meeting 2012 on Tuesday, April 3 by scientists at Fox Chase Cancer Center in Philadelphia.

PHILADELPHIA (April 2, 2012) — Registered nurse Sue Coady is the first Fox Chae nurse to receive the DAISY Award for Extraordinary Nurses. The award celebrates the clinical skill and compassionate care given by nurses in all types of settings.

CHICAGO, IL (April 2, 2012) – Latest findings from Fox Chase Cancer Center reveal that targeting inflammatory pathways may lead to new therapies.

CHICAGO, IL (April 2, 2012) – Results could lead to personalized treatment strategies for patients with this type of cancer.